FRESENIUS MEDICAL CARE-ADR (FMS:NYSE)
$22.95 -0.23 (-0.9922%)
Analysed FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) News Sources
Quest Diagnostics Q1 Earnings Call Highlights
21-04-2026
marketbeat.com
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
09-04-2026
yahoo.com
Focus Graphite Initiates Joint Development with Forge Nano to Evaluate Advanced Coating Technology for Lac Knife Graphite
09-04-2026
yahoo.com
Is Fresenius Medical Care (XTRA:FME) Now Attractively Priced After Years Of Share Price Weakness?
07-04-2026
yahoo.com
Fundamental Research Corp. Initiates Coverage on Focus Graphite Inc.
02-04-2026
yahoo.com
Here’s Why Fresenius Medical Care AG (FMS) Remains Attractive
31-03-2026
yahoo.com
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
25-03-2026
yahoo.com
Fresenius (FMS) is a Top-Ranked Value Stock: Should You Buy?
24-03-2026
yahoo.com
Fresenius Medical Care AG (FMS) Looks to Improve Profitability After Smashing Q4 Expectations
13-03-2026
yahoo.com
Here's Why Fresenius (FMS) is a Strong Value Stock
05-03-2026
yahoo.com
What is the current price of FRESENIUS MEDICAL CARE-ADR (FMS:NYSE)?
The current price of FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) is $22.95.
FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) absolute price change since previous trading day?
The absolute price change of FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) since the previous trading day is $-0.23.
FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) percentage price change since previous trading day?
The percentage price change of FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) since the previous trading day is -0.9922%.
What is the most recent average sentiment score for FRESENIUS MEDICAL CARE-ADR (FMS:NYSE)?
The most recent average sentiment score for FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) is 81 out of 100.
What is the most recent average sentiment for FRESENIUS MEDICAL CARE-ADR (FMS:NYSE)?
The most recent sentiment for FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) is .
SEC-8K** Filing Available For FRESENIUS MEDICAL CARE-ADR (FMS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.